A Novel Lipid Hydroperoxide-Derived Modification to Arginine

Chemical Research in Toxicology

Volumn 16, Issue 12, 2003, Pages 1598-1605

  Oe, Tomoyuki ^a   Lee, Seon Hwa ^a   Elipe, Maria V Silva ^b,c   Arison, Byron H ^b   Blair, Ian A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ARGININE; PEROXIDE;

ARTICLE; CAPILLARY CHROMATOGRAPHY; CYCLIZATION; DEHYDRATION; HEAT TREATMENT; LIPID PEROXIDATION; MICHAEL ADDITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN MODIFICATION; REACTION ANALYSIS;

ALDEHYDES; ARGININE; BOROHYDRIDES; CHROMATOGRAPHY, LIQUID; GUANIDINE; LIPID PEROXIDES; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; OXIDATION-REDUCTION;

EID: 0345737138     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034178l     Document Type: Article

References (30)

1. Ames, B. N., Shigenaga, M. K., and Hagen, T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90, 7915-7922.
2. Marnett, L. J. (2000) Oxyradicals and DNA damage. Carcinogenesis 21, 361-370.
3. Lee, S. H., and Blair, I. A. (2001) Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc. Med. 9, 148-155.
4. Blair, I. A. (2001) Lipid hydroperoxide-mediated DNA damage. Exp. Gerantol. 36, 1473-1481.
5. Lee, S. H., and Blair, I. A. (2000) Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 698-702.
6. Lee, S. H., Oe, T., and Blair, I. A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292, 2083-2086.
7. Rindgen, D., Nakajima, M., Wehrli, S., Xu, K., and Blair, I. A. (1999) Covalent modifications to 2′-deoxyguanosine by 4-oxo-2-nonenal a novel product of lipid peroxidation. Chem. Res. Toxicol. 12, 1195-1204.
8. 6-etheno-2′-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal. Chem. Res. Toxicol. 13, 846-852.
9. Lee, S. H., Rindgen, D., Bible, R. A., Hajdu, E., and Blair, I. A. (2000) Characterization of 2′-deoxyadenosine adducts derived from 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 565-574.
10. Pollack, M., Oe, T., Lee, S. H., Silva Elipe, M. V., Arison, B. H., and Blair, I. A. (2003) Characterization of 2′-Deoxycytidine Adducts Derived from 4-Oxo-2-nonenal, a Novel Lipid Peroxidation Product. Chem. Res. Toxicol. 16, 893-900.
11. Sayre, L. M., Arora, P. K., Iyer, R. S., and Salomon, R. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
12. Friguet, B., Stadtman, E. R., and Szweda, L. I. (1994) Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J. Biol. Chem. 269, 21639-21643.
13. Cohn, J. A., Tsai, L., Friguet, B., and Szweda, L. I. (1996) Chemical characterization of protein-4-hydroxy-2-nonenal cross-link: Immunochemical detection in mitochondria exposed to oxidative stress. Arch. Biochem. Biophys. 328, 158-164.
14. Xu, G., and Sayre, L. M. (1998) Structural characterization of a 4-hydroxy-2-alkenal-derived fluorophore that contributes to lipoperoxidation-dependent protein cross-linking in aging and degenerative disease. Chem. Res. Toxicol. 11, 247-251.
15. Xu, G., Liu, Y., Kansal, M. M., and Sayre, L. M. (1999) Rapid cross-linking of proteins by 4-keto aldehydes and 4-hydroxy-2-alkenals does not arise from the lysine-derived monoalkylpyrroles. Chem. Res. Toxicol. 12, 855-861.
16. Salomon, R. G., Kaur, K., Podrez, E., Hoff, H. F., Krushinsky, A. V., and Sayre, L. M. (2000) HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem. Res. Toxicol. 13, 557-564.
17. Hashimoto, M., Sibata, T., Wasada, H., Toyokuni, S., and Uchida, K. (2003) Chemical and immunochemical characterization of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct. J. Biol. Chem. 278, 5044-5051.
18. Doorn, J. A., and Petersen, D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15, 1445-1450.
19. Doorn, J. A., and Petersen, D. R. (2003) Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem.-Biol. Interact. 143-144, 93-100.
20. Esterbauer, H., and Weger, W. (1967) Über die wirkungen von aldehyden auf gesunde und maligne zellen, 3. mitt.: synthese von homologen 4-hydroxy-2-alkenalen, II. Monatsh. Chem. 98, 1994-2000.
21. Buettner, G. R., and Jurkiewicz, B. A. (1996) Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat. Res. 145, 532-541.
22. Roepstorff, P., and Fohlman, J. (1984) Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11, 601.
23. Johnson, R. S., Martin, S. A., Biemann, K., Stults, J. T., and Watson, J. T. (1987) Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucine. Anal. Chem. 59, 2621-2625.
24. Zhang, W. H., Liu, J., Xu, G., Yuan, Q., and Sayre, L. M. (2003) Model Studies on Protein Side Chain Modification by 4-Oxo-2-nonenal. Chem. Res. Toxicol. 16, 512-523.
25. Lederer, M. O., and Klaiber, R. G. (1999) Cross-linking of proteins by Maillard process: Characterization and detection of lysine-arginine cross-links derived from glyoxal and methylglyoxal. Bioorg. Med. Chem. 7, 2499-2507.
26. Glomb, M. A., and Lang, G. (2001) Isolation and characterization of glyoxal-arginine modifications. J. Agric. Food Chem. 49, 1493-1501.
27. Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T., and Uchida, K. (1999) Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274, 18492-18502.
28. Thornalley, P. J. (1998) Glutathione-dependent detoxification of a-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalaase I inhibitors. Chem.-Biol. Interact. 111-112, 137-151.
29. Moncada, S., and Higgs, E. A. (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9, 1319-1329.
30. Tsikas, D., Boger, R. H., Sandmann, J., Bode-Berger, S. M., and Frolich, J. C. (2000) Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett. 1-3.